Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$22,750,124
+$725,347 QoQ
Shares Held
89,578
-0.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#688
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $100,006,894 across 14 Drug Manufacturers - General names. JNJ ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,430 | $35,299,227 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
89,578 | $22,750,124 | |
| 3 | ABBV |
AbbVie Inc.
|
72,344 | $18,204,644 | |
| 4 | MRK |
Merck & Co., Inc.
|
136,408 | $17,528,428 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
37,785 | $2,177,171 | |
| 6 | NVS |
Novartis AG
|
7,847 | $1,229,781 | |
| 7 | PFE |
Pfizer Inc
|
50,191 | $1,208,599 | |
| 8 | AMGN |
Amgen Inc
|
2,744 | $993,657 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,750,124 | 89,578 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $22,024,777 | 90,103 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $18,224,430 | 88,062 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $15,727,324 | 84,820 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,476,674 | 88,227 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $15,731,582 | 94,860 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $14,171,313 | 97,990 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $17,430,039 | 107,553 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $15,684,721 | 107,312 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $17,301,082 | 109,369 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $17,975,570 | 114,684 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $18,198,764 | 116,846 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $19,974,126 | 120,675 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $18,205,215 | 117,453 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $20,829,508 | 117,914 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $19,511,718 | 119,440 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $20,851,744 | 117,468 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $21,070,697 | 118,889 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $20,196,524 | 118,060 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $19,204,611 | 118,914 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $18,880,851 | 114,610 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $18,892,525 | 114,953 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $18,170,622 | 115,457 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $16,731,581 | 112,383 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $16,191,575 | 115,136 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $14,843,784 | 113,199 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||